ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.

导出原文传递

翻译打印收藏纠错

第一作者： Xiangguo,Yu

第一单位： Key Laboratory for Experimental Teratology of Ministry of Education and Department of Immunology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, PR China.

作者： Xiangguo,Yu ^[1] ; Qinghai,Lin ^[1] ; Zhuanchang,Wu ^[1] ; Yankun,Zhang ^[1] ; Tixiao,Wang ^[1] ; Songbai,Zhao ^[1] ; Xiaojia,Song ^[1] ; Chaojia,Chen ^[1] ; Zehua,Wang ^[1] ; Leiqi,Xu ^[2] ; Chunyang,Li ^[1] ; Lifen,Gao ^[1] ; Xiaohong,Liang ^[1] ; Xuetian,Yue ^[3] ; Chunhong,Ma ^[1]

作者单位： Key Laboratory for Experimental Teratology of Ministry of Education and Department of Immunology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, PR China. ^[1] Department of Gastroenterology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, PR China. ^[2] Key Laboratory for Experimental Teratology of Ministry of Education and Department of Cell Biology, School of Basic Medical Science, Cheeloo College of Medicine, Shandong University, Jinan, PR China. ^[3] Advanced Medical Research Institute, Cheeloo College of Medicine, Shandong University, Jinan, PR China. ^[4]

关键词 HCC SREBP1c ZHX2 de novo lipogenesis